Helen Diller Family Comprehensive Cancer Center at UCSF

1:47

My Palliative Care Moment, Dr. Michael Rabow

Team Xplore

Dec 31, 2015

1213 views

Dr. Michael Rabow of the UCSF Helen Diller Family Comprehensive Cancer Center tells his palliative care moment.

4:05

Genetics Counseling for Ovarian Cancer Risk

Team Xplore

Dec 31, 2015

1022 views

One in 10-12 women with ovarian cancer has a hereditary cause of the ovarian cancer. Carefully collected three-generation pedigrees can help to determine which women should pursue genetic testing for hereditary causes of ovarian cancer, says Dr. Mary S. Beattie in this interview.

Mary S. Beattie, MD
Associate Clinical Professor of Medicine; Director, Clinical Research, UCSF Cancer Risk Program
UCSF Helen Diller Family Comprehensive Cancer Center

3:36

New Frontiers in Hormone Therapy for Breast Cancer

Team Xplore

Dec 31, 2015

1114 views

Hormone therapy is a standard treatment for both early-stage and metastatic breast cancer. New studies show that extending the duration of treatment in post-menopausal women beyond the standard five years may reduce cancer recurrence and improve survival.

Hope S. Rugo, MD
Clinical Professor of Medicine; Director, Breast Oncology Clinical Trials Program
UCSF Helen Diller Family Comprehensive Cancer Center

1:40

UCSF - Helen Diller Family Comprehensive Cancer Center

Team Xplore

Dec 31, 2015

1333 views

Learn more about how UCSF's expert team is advancing cancer care and research worldwide.

3:10

Accelerate Research for a Cancer-Free World!

Team Xplore

Dec 31, 2015

1283 views

Researchers at UC San Francisco are leading the way in identifying new pathways to treating many types of cancer. You can be a part of this movement by contributing directly to the UCSF Helen Diller Family Comprehensive Cancer Center. Give today at http://proj.at/1anxbig

3:14

UCSF Grand MMTI Shows Results, Thanks Supporters

Team Xplore

Dec 31, 2015

1405 views

The Stephen and Nancy Grand Multiple Myeloma Translational Initiative at UCSF - Speeding the development of improved therapies for multiple myeloma patients. Learn how you can help!